Market Intelligence
Vietnam Pharmaceutical Market Report — Q4 2025
Comprehensive market update for international pharmaceutical partners. A concise read on where Vietnam’s pharmaceutical market is heading and where the growth is concentrated.
Sources: IQVIA VTMA · BMI Fitch Solutions · Vietnam Market Outlook · WHO Healthcare System Data
Market value FY 2025
234,794 bn ₫
~USD 9bn · ▲ 5% YoY
SEA ranking
2nd in Southeast Asia
Hospital 60% · Retail 40%
2029 outlook
USD 9.2bn
CAGR 9%/yr
Generic share by 2029
62%
of total market
Free. We’ll email you the full report (business email required).
What’s inside
- ▸Market overview & 2024–2029 outlook
- ▸Channel analysis — hospital vs. retail
- ▸Therapy-class dynamics (hospital)
- ▸Top 10 corporations & 2025 launches
- ▸Health insurance & infrastructure
- ▸Southeast Asia regional positioning
Southeast Asia ranking (MAT Q4 2025)
| Country | Sales (USD Mn) | YoY |
|---|---|---|
| Thailand | 9,040 | ▲ 14% |
| Vietnam | 9,026 | ▲ 1% |
| Philippines | 5,410 | ▲ 7% |
Channel growth (CAGR 2021–2025)
| Channel | 2025 | CAGR |
|---|---|---|
| Government Hospital | ▲ 5% | 18.3% |
| Private Hospital | ▲ 15% | 24.0% |
| Total Hospital | ▲ 7% | 19.4% |
Pharmacy chains: 44.9% CAGR over five years.
Get the full picture
The full report includes the product-mix breakdown, hospital therapy-class table, top-10 corporations, 2025 launches, and the SHI / infrastructure data.